IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery

S196 The present and the future of toxins: what's new

sábado 28 janeiro 2023

14:00 to 15:30

Amphi Bleu - Level 2

FOCUS SESSION

Presidente (s) da sessão

Dr. Benjamin ASCHER

Cirurgião Plástico

França

Dr. Philippe PICAUT

PhD - Investigação

França

Palestras da sessão

14:00

Introduction by the chairs

14:02

Dr. Philippe PICAUT

Toxins overview: 2023 update

14:10

Dr. Michael CECERLE

LetibotulinumtoxinA: what’s new 1 year after approval? (Croma)

14:10

Part 1 - Future botulinum toxins to arrive on the European market

14:18

Dr. Rui AVELAR

Prabotulinumtoxin longer duration formulation first interim analysis (Evolus)

14:26

Dr. Conor GALLAGHER

DaxibotulinumtoxinA for injection: the new FDA-approved long lasting botulinum toxin formulation (Revance)

14:34

Panel discussion

14:49

Part 2 - Novel botulinum toxins

14:49

Mickael MACHICOANE

How to boost your usual toxin performance? (Fastox)

14:57

Xiaoming LIN

RelabotulinumtoxinA: proprietary strain and liquid manufacturing process for a novel long-lasting neuromodulator (Galderma)

15:05

Jon EDELSON

ET-01 – A phase 2b topical botulinum product candidate (Eirion)

15:13

Panel discussion

Sessões recomendadas

Optional course - Lip fillers: Russian, Brazilian, or Middle Eastern? S126

Open stage - Scientific lectures - Injectables OS S003 to S006

Indústria Simpósio

SINCLAIR Symposium - Facial and body rejuvenation using Lanluma®, a PLLA collagen stimulating injectable, and the V-Series, a multi-technology platform S164

Indústria Simpósio

FIDIA PHARMA Symposium - Discover a new generation of injectables with 200kDa HA and the pure science behind S160

Indústria Simpósio

GALDERMA Symposium - Our aesthetic lives: a long-term journey into aesthetic treatments S113, S114

Tem uma pergunta?

Aviso

Presidente (s) da sessão

Palestras da sessão

Sessões recomendadas

Tem uma pergunta?

Erro